APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Intestinal Medicine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pet Intestinal Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchPet Intestinal Medicine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Intestinal Medicine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Pet Intestinal Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Intestinal Medicine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Intestinal Medicine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pet Intestinal Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pet Intestinal Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Intestinal Medicine include Boehringer Ingelheim, CAHIC, Ceva, Dechra Veterinary Products, Elanco, Jindun, Norbrook, Ouro Fino Saude and Vetoquinol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Intestinal Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Intestinal Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Intestinal Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Intestinal Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Intestinal Medicine Segment by Company

Boehringer Ingelheim

CAHIC

Ceva

Dechra Veterinary Products

Elanco

Jindun

Norbrook

Ouro Fino Saude

Vetoquinol

Virbac

Wuhan chopperlvya

Merck

Zoetis

Pet Intestinal Medicine Segment by Type

Powder

Liquid

Pet Intestinal Medicine Segment by Application

Reptile

Cat

Dog

Other

Pet Intestinal Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Intestinal Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Intestinal Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Intestinal Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Intestinal Medicine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pet Intestinal Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pet Intestinal Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pet Intestinal Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pet Intestinal Medicine Industry Trends Table 2. Pet Intestinal Medicine Industry Drivers Table 3. Pet Intestinal Medicine Industry Opportunities and Challenges Table 4. Pet Intestinal Medicine Industry Restraints Table 5. Global Pet Intestinal Medicine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pet Intestinal Medicine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pet Intestinal Medicine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Pet Intestinal Medicine Sales Market Share by Manufacturers Table 9. Global Pet Intestinal Medicine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Pet Intestinal Medicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pet Intestinal Medicine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pet Intestinal Medicine Manufacturers, Product Type & Application Table 13. Global Pet Intestinal Medicine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Intestinal Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Powder Table 17. Major Manufacturers of Liquid Table 18. Global Pet Intestinal Medicine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Pet Intestinal Medicine Sales by Type (2021-2026) & (k units) Table 20. Global Pet Intestinal Medicine Sales by Type (2027-2032) & (k units) Table 21. Global Pet Intestinal Medicine Sales Market Share by Type (2021-2026) Table 22. Global Pet Intestinal Medicine Sales Market Share by Type (2027-2032) Table 23. Global Pet Intestinal Medicine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Pet Intestinal Medicine Revenue by Type (2021-2026) & (k units) Table 25. Global Pet Intestinal Medicine Revenue by Type (2027-2032) & (k units) Table 26. Global Pet Intestinal Medicine Revenue Market Share by Type (2021-2026) Table 27. Global Pet Intestinal Medicine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Reptile Table 29. Major Manufacturers of Cat Table 30. Major Manufacturers of Dog Table 31. Major Manufacturers of Other Table 32. Global Pet Intestinal Medicine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Pet Intestinal Medicine Sales by Application (2021-2026) & (k units) Table 34. Global Pet Intestinal Medicine Sales by Application (2027-2032) & (k units) Table 35. Global Pet Intestinal Medicine Sales Market Share by Application (2021-2026) Table 36. Global Pet Intestinal Medicine Sales Market Share by Application (2027-2032) Table 37. Global Pet Intestinal Medicine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Pet Intestinal Medicine Revenue by Application (2021-2026) & (k units) Table 39. Global Pet Intestinal Medicine Revenue by Application (2027-2032) & (k units) Table 40. Global Pet Intestinal Medicine Revenue Market Share by Application (2021-2026) Table 41. Global Pet Intestinal Medicine Revenue Market Share by Application (2027-2032) Table 42. Global Pet Intestinal Medicine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Pet Intestinal Medicine Sales by Region (2021-2026) & (k units) Table 44. Global Pet Intestinal Medicine Sales Market Share by Region (2021-2026) Table 45. Global Pet Intestinal Medicine Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Pet Intestinal Medicine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pet Intestinal Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Pet Intestinal Medicine Sales by Country (2021-2026) & (k units) Table 49. North America Pet Intestinal Medicine Sales by Country (2027-2032) & (k units) Table 50. Europe Pet Intestinal Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Pet Intestinal Medicine Sales by Country (2021-2026) & (k units) Table 52. Europe Pet Intestinal Medicine Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Pet Intestinal Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Pet Intestinal Medicine Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Pet Intestinal Medicine Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Pet Intestinal Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Pet Intestinal Medicine Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Pet Intestinal Medicine Sales by Country (2027-2032) & (k units) Table 59. Global Pet Intestinal Medicine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pet Intestinal Medicine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pet Intestinal Medicine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pet Intestinal Medicine Revenue Market Share by Region (2021-2026) Table 63. Global Pet Intestinal Medicine Revenue Market Share by Region (2027-2032) Table 64. Boehringer Ingelheim Company Information Table 65. Boehringer Ingelheim Business Overview Table 66. Boehringer Ingelheim Pet Intestinal Medicine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Boehringer Ingelheim Pet Intestinal Medicine Product Portfolio Table 68. Boehringer Ingelheim Recent Development Table 69. CAHIC Company Information Table 70. CAHIC Business Overview Table 71. CAHIC Pet Intestinal Medicine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. CAHIC Pet Intestinal Medicine Product Portfolio Table 73. CAHIC Recent Development Table 74. Ceva Company Information Table 75. Ceva Business Overview Table 76. Ceva Pet Intestinal Medicine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Ceva Pet Intestinal Medicine Product Portfolio Table 78. Ceva Recent Development Table 79. Dechra Veterinary Products Company Information Table 80. Dechra Veterinary Products Business Overview Table 81. Dechra Veterinary Products Pet Intestinal Medicine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Dechra Veterinary Products Pet Intestinal Medicine Product Portfolio Table 83. Dechra Veterinary Products Recent Development Table 84. Elanco Company Information Table 85. Elanco Business Overview Table 86. Elanco Pet Intestinal Medicine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Elanco Pet Intestinal Medicine Product Portfolio Table 88. Elanco Recent Development Table 89. Jindun Company Information Table 90. Jindun Business Overview Table 91. Jindun Pet Intestinal Medicine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Jindun Pet Intestinal Medicine Product Portfolio Table 93. Jindun Recent Development Table 94. Norbrook Company Information Table 95. Norbrook Business Overview Table 96. Norbrook Pet Intestinal Medicine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Norbrook Pet Intestinal Medicine Product Portfolio Table 98. Norbrook Recent Development Table 99. Ouro Fino Saude Company Information Table 100. Ouro Fino Saude Business Overview Table 101. Ouro Fino Saude Pet Intestinal Medicine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Ouro Fino Saude Pet Intestinal Medicine Product Portfolio Table 103. Ouro Fino Saude Recent Development Table 104. Vetoquinol Company Information Table 105. Vetoquinol Business Overview Table 106. Vetoquinol Pet Intestinal Medicine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Vetoquinol Pet Intestinal Medicine Product Portfolio Table 108. Vetoquinol Recent Development Table 109. Virbac Company Information Table 110. Virbac Business Overview Table 111. Virbac Pet Intestinal Medicine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Virbac Pet Intestinal Medicine Product Portfolio Table 113. Virbac Recent Development Table 114. Wuhan chopperlvya Company Information Table 115. Wuhan chopperlvya Business Overview Table 116. Wuhan chopperlvya Pet Intestinal Medicine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Wuhan chopperlvya Pet Intestinal Medicine Product Portfolio Table 118. Wuhan chopperlvya Recent Development Table 119. Merck Company Information Table 120. Merck Business Overview Table 121. Merck Pet Intestinal Medicine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Merck Pet Intestinal Medicine Product Portfolio Table 123. Merck Recent Development Table 124. Zoetis Company Information Table 125. Zoetis Business Overview Table 126. Zoetis Pet Intestinal Medicine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Zoetis Pet Intestinal Medicine Product Portfolio Table 128. Zoetis Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Pet Intestinal Medicine Distributors List Table 132. Pet Intestinal Medicine Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Pet Intestinal Medicine Product Image Figure 2. Global Pet Intestinal Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Intestinal Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Intestinal Medicine Sales (2021-2032) & (k units) Figure 5. Global Pet Intestinal Medicine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pet Intestinal Medicine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Powder Image Figure 9. Liquid Image Figure 10. Global Pet Intestinal Medicine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Pet Intestinal Medicine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pet Intestinal Medicine Sales Market Share by Type (2021-2032) Figure 13. Global Pet Intestinal Medicine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Pet Intestinal Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pet Intestinal Medicine Revenue Market Share by Type (2021-2032) Figure 16. Reptile Image Figure 17. Cat Image Figure 18. Dog Image Figure 19. Other Image Figure 20. Global Pet Intestinal Medicine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Pet Intestinal Medicine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pet Intestinal Medicine Sales Market Share by Application (2021-2032) Figure 23. Global Pet Intestinal Medicine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Pet Intestinal Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pet Intestinal Medicine Revenue Market Share by Application (2021-2032) Figure 26. North America Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Pet Intestinal Medicine Sales Market Share by Country (2021-2032) Figure 28. U.S. Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Pet Intestinal Medicine Sales Market Share by Country (2021-2032) Figure 33. Germany Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Pet Intestinal Medicine Sales Market Share by Country (2021-2032) Figure 40. China Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Pet Intestinal Medicine Sales Market Share by Country (2021-2032) Figure 48. Brazil Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Pet Intestinal Medicine Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Pet Intestinal Medicine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pet Intestinal Medicine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pet Intestinal Medicine Revenue (2021-2032) & (US$ Million) Figure 59. North America Pet Intestinal Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pet Intestinal Medicine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pet Intestinal Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pet Intestinal Medicine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pet Intestinal Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pet Intestinal Medicine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pet Intestinal Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pet Intestinal Medicine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pet Intestinal Medicine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Liquid
Applications
  • Reptile
  • Cat
  • Dog
  • Other
Companies covered
  • Boehringer Ingelheim
  • CAHIC
  • Ceva
  • Dechra Veterinary Products
  • Elanco
  • Jindun
  • Norbrook
  • Ouro Fino Saude
  • Vetoquinol
  • Virbac
  • Wuhan chopperlvya
  • Merck
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pet Intestinal Medicine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pet Intestinal Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pet Intestinal Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pet Intestinal Medicine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pet Intestinal Medicine Market Dynamics
  1. 2.1 Pet Intestinal Medicine Industry Trends
  2. 2.2 Pet Intestinal Medicine Industry Drivers
  3. 2.3 Pet Intestinal Medicine Industry Opportunities and Challenges
  4. 2.4 Pet Intestinal Medicine Industry Restraints
3 Pet Intestinal Medicine Market by Manufacturers
  1. 3.1 Global Pet Intestinal Medicine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pet Intestinal Medicine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pet Intestinal Medicine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pet Intestinal Medicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pet Intestinal Medicine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pet Intestinal Medicine Manufacturers, Product Type & Application
  7. 3.7 Global Pet Intestinal Medicine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pet Intestinal Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pet Intestinal Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pet Intestinal Medicine Tier 1, Tier 2, and Tier 3
4 Pet Intestinal Medicine Market by Type
  1. 4.1 Pet Intestinal Medicine Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Liquid
  4. 4.2 Global Pet Intestinal Medicine Sales by Type
  5. 4.2.1 Global Pet Intestinal Medicine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pet Intestinal Medicine Sales by Type (2021-2032)
  7. 4.2.3 Global Pet Intestinal Medicine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pet Intestinal Medicine Revenue by Type
  9. 4.3.1 Global Pet Intestinal Medicine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pet Intestinal Medicine Revenue by Type (2021-2032)
  11. 4.3.3 Global Pet Intestinal Medicine Revenue Market Share by Type (2021-2032)
5 Pet Intestinal Medicine Market by Application
  1. 5.1 Pet Intestinal Medicine Application Introduction
  2. 5.1.1 Reptile
  3. 5.1.2 Cat
  4. 5.1.3 Dog
  5. 5.1.4 Other
  6. 5.2 Global Pet Intestinal Medicine Sales by Application
  7. 5.2.1 Global Pet Intestinal Medicine Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pet Intestinal Medicine Sales by Application (2021-2032)
  9. 5.2.3 Global Pet Intestinal Medicine Sales Market Share by Application (2021-2032)
  10. 5.3 Global Pet Intestinal Medicine Revenue by Application
  11. 5.3.1 Global Pet Intestinal Medicine Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pet Intestinal Medicine Revenue by Application (2021-2032)
  13. 5.3.3 Global Pet Intestinal Medicine Revenue Market Share by Application (2021-2032)
6 Global Pet Intestinal Medicine Sales by Region
  1. 6.1 Global Pet Intestinal Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Intestinal Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Intestinal Medicine Sales by Region (2021-2026)
  4. 6.2.2 Global Pet Intestinal Medicine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pet Intestinal Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pet Intestinal Medicine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pet Intestinal Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pet Intestinal Medicine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pet Intestinal Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pet Intestinal Medicine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pet Intestinal Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pet Intestinal Medicine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pet Intestinal Medicine Revenue by Region
  1. 7.1 Global Pet Intestinal Medicine Revenue by Region
  2. 7.1.1 Global Pet Intestinal Medicine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pet Intestinal Medicine Revenue by Region (2021-2026)
  4. 7.1.3 Global Pet Intestinal Medicine Revenue by Region (2027-2032)
  5. 7.1.4 Global Pet Intestinal Medicine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pet Intestinal Medicine Revenue (2021-2032)
  8. 7.2.2 North America Pet Intestinal Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pet Intestinal Medicine Revenue (2021-2032)
  11. 7.3.2 Europe Pet Intestinal Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pet Intestinal Medicine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pet Intestinal Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pet Intestinal Medicine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pet Intestinal Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Pet Intestinal Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Pet Intestinal Medicine Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 CAHIC
  8. 8.2.1 CAHIC Company Information
  9. 8.2.2 CAHIC Business Overview
  10. 8.2.3 CAHIC Pet Intestinal Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CAHIC Pet Intestinal Medicine Product Portfolio
  12. 8.2.5 CAHIC Recent Developments
  13. 8.3 Ceva
  14. 8.3.1 Ceva Company Information
  15. 8.3.2 Ceva Business Overview
  16. 8.3.3 Ceva Pet Intestinal Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ceva Pet Intestinal Medicine Product Portfolio
  18. 8.3.5 Ceva Recent Developments
  19. 8.4 Dechra Veterinary Products
  20. 8.4.1 Dechra Veterinary Products Company Information
  21. 8.4.2 Dechra Veterinary Products Business Overview
  22. 8.4.3 Dechra Veterinary Products Pet Intestinal Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dechra Veterinary Products Pet Intestinal Medicine Product Portfolio
  24. 8.4.5 Dechra Veterinary Products Recent Developments
  25. 8.5 Elanco
  26. 8.5.1 Elanco Company Information
  27. 8.5.2 Elanco Business Overview
  28. 8.5.3 Elanco Pet Intestinal Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Elanco Pet Intestinal Medicine Product Portfolio
  30. 8.5.5 Elanco Recent Developments
  31. 8.6 Jindun
  32. 8.6.1 Jindun Company Information
  33. 8.6.2 Jindun Business Overview
  34. 8.6.3 Jindun Pet Intestinal Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jindun Pet Intestinal Medicine Product Portfolio
  36. 8.6.5 Jindun Recent Developments
  37. 8.7 Norbrook
  38. 8.7.1 Norbrook Company Information
  39. 8.7.2 Norbrook Business Overview
  40. 8.7.3 Norbrook Pet Intestinal Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Norbrook Pet Intestinal Medicine Product Portfolio
  42. 8.7.5 Norbrook Recent Developments
  43. 8.8 Ouro Fino Saude
  44. 8.8.1 Ouro Fino Saude Company Information
  45. 8.8.2 Ouro Fino Saude Business Overview
  46. 8.8.3 Ouro Fino Saude Pet Intestinal Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ouro Fino Saude Pet Intestinal Medicine Product Portfolio
  48. 8.8.5 Ouro Fino Saude Recent Developments
  49. 8.9 Vetoquinol
  50. 8.9.1 Vetoquinol Company Information
  51. 8.9.2 Vetoquinol Business Overview
  52. 8.9.3 Vetoquinol Pet Intestinal Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Vetoquinol Pet Intestinal Medicine Product Portfolio
  54. 8.9.5 Vetoquinol Recent Developments
  55. 8.10 Virbac
  56. 8.10.1 Virbac Company Information
  57. 8.10.2 Virbac Business Overview
  58. 8.10.3 Virbac Pet Intestinal Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Virbac Pet Intestinal Medicine Product Portfolio
  60. 8.10.5 Virbac Recent Developments
  61. 8.11 Wuhan chopperlvya
  62. 8.11.1 Wuhan chopperlvya Company Information
  63. 8.11.2 Wuhan chopperlvya Business Overview
  64. 8.11.3 Wuhan chopperlvya Pet Intestinal Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Wuhan chopperlvya Pet Intestinal Medicine Product Portfolio
  66. 8.11.5 Wuhan chopperlvya Recent Developments
  67. 8.12 Merck
  68. 8.12.1 Merck Company Information
  69. 8.12.2 Merck Business Overview
  70. 8.12.3 Merck Pet Intestinal Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Pet Intestinal Medicine Product Portfolio
  72. 8.12.5 Merck Recent Developments
  73. 8.13 Zoetis
  74. 8.13.1 Zoetis Company Information
  75. 8.13.2 Zoetis Business Overview
  76. 8.13.3 Zoetis Pet Intestinal Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Zoetis Pet Intestinal Medicine Product Portfolio
  78. 8.13.5 Zoetis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Intestinal Medicine Value Chain Analysis
  2. 9.1.1 Pet Intestinal Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Intestinal Medicine Production Mode & Process
  6. 9.2 Pet Intestinal Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Intestinal Medicine Distributors
  9. 9.2.3 Pet Intestinal Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst